Largest pharmaceutical companies in the United States by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by net assets, at THB 2.94T, ahead of Johnson & Johnson (THB 2.77T) and Merck & Co (THB 1.79T). Figures as of 20 Nov 2026, 04:38 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerTHB 2.94T
- Median
- THB 22.2B
- Combined market value
- THB 126.83T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | THB 2.94T | THB 5.33T | THB 934.98 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | THB 2.77T | THB 21.83T | THB 9,069.40 | 2.04% down | 34% up | ||
| 3 | Merck & CoMRK · Health Care | THB 1.79T | THB 11.12T | THB 4,508.90 | 3.61% down | 45% up | ||
| 4 | Abbott LaboratoriesABT · Health Care | THB 1.77T | THB 6.11T | THB 3,526.39 | 0.58% down | 16% down | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | THB 1.06T | THB 3.24T | THB 31,347.39 | 2.35% down | 28% up | ||
| 6 | Eli LillyLLY · Health Care | THB 900.9B | THB 40.86T | THB 45,870.52 | 2.29% down | 33% up | ||
| 7 | Vertex PharmaceuticalsVRTX · Health Care | THB 633.7B | THB 4.48T | THB 17,676.41 | 2.94% down | 27% up | ||
| 8 | Bristol-Myers SquibbBMY · Health Care | THB 627.2B | THB 4.05T | THB 1,980.64 | 2.05% down | 30% up | ||
| 9 | ViatrisVTRS · Health Care | THB 499.4B | THB 773.8B | THB 674.93 | 1.97% down | 99% up | ||
| 10 | Royalty PharmaRPRX · Health Care | THB 329.8B | THB 1.32T | THB 2,299.09 | 1.38% down | 79% up | ||
| 11 | United TherapeuticsUTHR · Health Care | THB 240.9B | THB 808.4B | THB 18,981.45 | 3.16% down | 22% up | ||
| 12 | Elanco Animal HealthELAN · Health Care | THB 222.3B | THB 446.1B | THB 892.55 | 1.54% down | 26% up | ||
| 13 | BioMarin PharmaceuticalBMRN · Health Care | THB 206.7B | THB 403.9B | THB 2,085.21 | 0.02% down | 17% up | ||
| 14 | ZoetisZTS · Health Care | THB 113.1B | THB 1.11T | THB 2,742.82 | 5.59% down | 26% down | ||
| 15 | Ligand PharmaceuticalsLGND · Health Care | THB 34.5B | THB 194.9B | THB 9,741.61 | 3.94% down | 50% up | ||
| 16 | Legend BiotechLEGN · Health Care | THB 34B | THB 106B | THB 546.60 | 0.92% down | 41% down | ||
| 17 | Praxis Precision MedicinesPRAX · Health Care | THB 29.8B | THB 295B | THB 10,555.06 | 1.87% up | 86% up | ||
| 18 | Alnylam PharmaceuticalsALNY · Health Care | THB 26.8B | THB 672.2B | THB 5,018.49 | 1.06% down | 66% down | ||
| 19 | Belite BioBLTE · Health Care | THB 26.2B | THB 208.2B | THB 5,127.13 | 3.33% down | 43% up | ||
| 20 | InsmedINSM · Health Care | THB 25.1B | THB 1.08T | THB 4,904.42 | 20.58% up | 40% down | ||
| 21 | Spyre TherapeuticsSYRE · Health Care | THB 24.3B | THB 314.8B | THB 3,314.54 | 3.77% down | 332% up | ||
| 22 | Summit TherapeuticsSMMT · Health Care | THB 22.4B | THB 287B | THB 358.85 | 0.67% up | 36% down | ||
| 23 | TG TherapeuticsTGTX · Health Care | THB 22B | THB 332.9B | THB 2,202.68 | 1.88% down | 117% up | ||
| 24 | Corcept TherapeuticsCORT · Health Care | THB 22B | THB 241.4B | THB 2,206.07 | 4.15% down | 10% down | ||
| 25 | Cogent BiosciencesCOGT · Health Care | THB 21.6B | THB 163.9B | THB 941.77 | 0.25% down | 20% down | ||
| 26 | Protagonist TherapeuticsPTGX · Health Care | THB 20.9B | THB 274.8B | THB 4,210.48 | 2.47% down | 51% up | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | THB 20.5B | THB 312.9B | THB 13,469.32 | 0.34% down | 27% down | ||
| 28 | Edgewise TherapeuticsEWTX · Health Care | THB 17.7B | THB 153B | THB 1,397.72 | 0.48% down | 86% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | THB 16.8B | THB 162.2B | THB 2,879.98 | 1.01% up | 108% up | ||
| 30 | Ionis PharmaceuticalsIONS · Health Care | THB 16.6B | THB 153.9B | THB 924.12 | 0.62% down | 63% down | ||
| 31 | Oruka TherapeuticsORKA · Health Care | THB 16B | THB 224.7B | THB 3,312.50 | 1.91% up | 255% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | THB 15.8B | THB 209.5B | THB 1,481.92 | 1.25% up | 13% up | ||
| 33 | Definium TherapeuticsDFTX · Health Care | THB 11.3B | THB 137B | THB 1,000.85 | 1.24% up | 168% up | ||
| 34 | ErascaERAS · Health Care | THB 11B | THB 169.4B | THB 482.77 | 3.34% up | 395% up | ||
| 35 | Mirum PharmaceuticalsMIRM · Health Care | THB 10.7B | THB 211.7B | THB 3,242.56 | 3.27% up | 34% up | ||
| 36 | Rhythm PharmaceuticalsRYTM · Health Care | THB 4.7B | THB 274.9B | THB 3,965.36 | 1.88% down | 18% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | THB 3.9B | THB 157.4B | THB 1,639.79 | 3.86% down | 45% up | ||
| 38 | Axsome TherapeuticsAXSM · Health Care | THB 3B | THB 242.3B | THB 4,606.34 | 1.25% up | 6% down | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | -THB 2.4B | THB 253B | THB 726.19 | 2.24% down | 90% up | ||
| 40 | VeradermicsMANE · Health Care | -THB 4.1B | THB 178.2B | THB 4,223.04 | 0.38% down | 231% up | ||
| 41 | PTC TherapeuticsPTCT · Health Care | -THB 7B | THB 165.4B | THB 1,980.13 | 3.16% down | 21% down | ||
| 42 | CytokineticsCYTK · Health Care | -THB 22.4B | THB 243.4B | THB 1,747.07 | 0.27% up | 19% down | ||
| 43 | BridgeBio PharmaBBIO · Health Care | -THB 70.8B | THB 517B | THB 2,654.21 | 0.22% up | 21% up | ||
| 44 | AbbVieABBV · Health Care | -THB 111B | THB 17.02T | THB 9,626.18 | 0.86% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9500 THB).
Questions and answers
Which pharmaceutical companies in the United States rank first by net assets?
Pfizer (THB 2.94T), Johnson & Johnson (THB 2.77T) and Merck & Co (THB 1.79T) are the top three of the 44 pharmaceutical companies in the United States ranked by net assets as of 20 Nov 2026, 04:38 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by net assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by net assets have a combined market value of THB 126.83T as of 20 Nov 2026, 04:38 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.